Home | Welcome to Contract Pharma   
Last Updated Thursday, April 17 2014
Print

Topics - Drug Discovery


Refine by Date:
From: To:
Published April 16, 2014
Will transition DDS ops to other sites Read More »
Published April 4, 2014
Will be used to enhance infectious disease development program Read More »
Published April 2, 2014
To develop compounds for the potential treatment of cancer Read More »
Published April 1, 2014
Adds Trianni Mouse to biologic research capabilities Read More »
Published April 1, 2014
To evaluate biomarkers for the discovery of novel therapies Read More »
Published April 1, 2014
Stay tuned for Contract Pharma's Newsmaker interview with CEO, James Foster Read More »
Published March 31, 2014
To discover and develop compounds against GPCR pain target Read More »
By Kristin Brooks
Published March 26, 2014
Xenon will employ Extreme Genetics discovery platform Read More »
By Kristin Brooks
Published March 24, 2014
Expands Life Sciences business discovery and manufacturing services Read More »
By Kristin Brooks
Published March 24, 2014
Expands discovery pipeline in multiple sclerosis and CNS Read More »
By Kristin Brooks
Published March 21, 2014
Will evaluate VELTIS technology for potential drug candidates Read More »
By Kristin Brooks
Published March 21, 2014
Will use POTELLIGENT CHOK1SV for antibody development Read More »
By Kristin Brooks
Published March 21, 2014
Adds biopharma assessment services Read More »
By Kristin Brooks
Published March 19, 2014
Will utilize each other's assets to foster open innovation Read More »
By Kristin Brooks
Published March 17, 2014
Opens lab in Germany Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On